Smith and Nephew Continues to Deliver its Strategic Priorities
Company to introduce new and innovative products at the American
Academy of Orthopaedic Surgeons 2010 Annual Meeting in New Orleans
Representatives from across the business to attend
London, United Kingdom, March 8, 2010 - Smith & Nephew plc (LSE: SN,
NYSE: SNN), the global medical technology business, continues to
deliver on its strategic priorities by introducing new and innovative
products from its Orthopedics and Endoscopy business units at this
yearOs American Academy of Orthopaedic Surgeons ("AAOS") Annual
Meeting. Smith & Nephew's presence at this year's Annual Meeting will
feature the launch of several new products, as well as advances in
Smith & Nephew's current portfolio, and representatives from Smith &
Nephew Orthopaedic's medical education platform, KLEOS, will be on
hand. The combined success of Smith & Nephew's Orthopaedics,
Endoscopy, Advanced Wound Management and Biologics & Clinical
Therapies,businesses reflects Smith & Nephew's continued focus on
providing its customers with innovative technologies, comprehensive
medical education and superior customer service."Despite a difficult
economic environment, 2009 was a year of strong
underlying growth for Smith & Nephew. This was a direct result of
Smith & Nephew's dedication to our customers and the products we
provide them with," said David Illingworth, Chief Executive of Smith &
Nephew. "We continue to invest in cutting-edge technologies that both
advance our existing products and position us to introduce new ones,
fulfilling our commitment to improve surgeon and patient options. We
are excited to showcase these advances and new product lines at the
AAOS Annual Meeting."
Management in attendance at this year's meeting will include Dave
Illingworth; Joe DeVivo, President Orthopaedics; Mike Frazzette,
President Endoscopy; Mark Augusti, President Biologics & Clinical
Therapies; and Tom Dugan, President North American Business, Advanced
Wound Management."
Mr. Illingworth continued, "We have extremely talented people leading
our global businesses and we welcome the opportunity to meet with
surgeons and other customers at our booth. We also have Orthopaedics'
medical education platform, KLEOS, at this year's meeting, which
includes industry-leading educational activities, such as MOBILAB,
surgical skills courses, and our new telementoring program. We look
forward to sharing our new products and ideas at our booth."
For more information on surgeon presentations and product
demonstrations, please visit Orthopaedics, Wound Management and
Biologics at booth 1629 and Endoscopy at booth 1643.
For more information about Smith & Nephew, please visit
www.smith-nephew.com.
Inquiries
Investors
Liz Hewitt +44 (0)20 7401 7646
Smith & Nephew
Group Director, Corporate Affairs
Phil Cowdy +44 (0)20 7401 7646
Smith & Nephew
Director - Investor Relations
Press +1 212 333 3810
Katie Cralle
Brunswick Group
About Us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies;
Endoscopy and Advanced Wound Management. Smith & Nephew is a global
leader in arthroscopy and advanced wound management and is one of the
leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The
Company prides itself on the strength of its relationships with its
surgeons and professional healthcare customers, with whom its name is
synonymous with high standards of performance, innovation and trust.
The Company operates in 32 countries around the world. Annual sales in
2009 were nearly $3.8 billion.
Forward-Looking Statements
This press release contains certain "forward-looking statements" within
the meaning of the US Private Securities Litigation Reform Act of
1995. In particular, statements regarding expected revenue growth and
trading margins discussed under "Outlook" are forward-looking
statements as are discussions of our product pipeline. These
statements, as well as the phrases "aim", "plan", "intend","anticipate",
"well-placed", "believe", "estimate", "expect", "target","consider"
and similar expressions, are generally intended to identify
forward-looking statements. Such forward-looking statements involve
known and unknown risks, uncertainties and other important factors
(including, but not limited to, the outcome of litigation, claims and
regulatory approvals) that could cause the actual results, performance
or achievements of Smith & Nephew, or industry results, to differ
materially from any future results, performance or achievements
expressed or implied by such forward-looking statements. Please refer
to the documents that Smith & Nephew has filed with the U.S. Securities
and Exchange Commission under the U.S. Securities Exchange Act of 1934,
as amended, including Smith & Nephew's most recent annual report on
Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on
information available to Smith & Nephew as of the date hereof. All
written or oral forward-looking statements attributable to Smith &
Nephew or any person acting on behalf of Smith & Nephew are expressly
qualified in their entirety by the foregoing. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement contained herein to reflect any change in Smith & Nephew's
expectation with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.
###
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com